Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: A phase I study

This publication has 34 references indexed in Scilit:

• A Pilot Study on Feasibility and Efficacy of Amifostine Preceding High-dose Melphalan with Autologous Stem Cell Support in Myeloma Patients
  Leukemia & Lymphoma, 2002
• Amifostine
  Drugs, 2001
• Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 2000
• Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors
  Bone Marrow Transplantation, 2000
• Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells
  Bone Marrow Transplantation, 1998
• A pilot study of 220 mg/m² melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity
  British Journal of Haematology, 1996
• Amifostine
  Drugs, 1995
• Überdosierung von Melphalan (Alkeran®): Symptome und Behandlung
  Oncology Research and Treatment, 1990
• Hypocalcemia and Inhibition of Parathyroid Hormone Secretion after Administration of WR-2721 (a Radioprotective and Chemoprotective Agent)
  New England Journal of Medicine, 1983
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958